Guangdie Yang Selected Research

Interleukin-10 (Interleukin 10)

5/2016	TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer.
1/2015	Interleukin-10 promoter gene polymorphisms and susceptibility to tuberculosis: a meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangdie Yang Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 08/2011
6	Lung Neoplasms (Lung Cancer) 04/2021 - 06/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2018
2	Asthma (Bronchial Asthma) 01/2019 - 01/2014
1	Lymphatic Metastasis 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Carcinogenesis 01/2020
1	Allergic Bronchopulmonary Aspergillosis 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Respiratory Hypersensitivity 01/2017
1	Inflammation (Inflammations) 01/2017
1	Infections 05/2016
1	Pleural Effusion (Pleural Effusions) 01/2015
1	Tuberculosis (Tuberculoses) 01/2015
1	Disease Progression 08/2011

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2022 - 05/2016
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 05/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2020
2	dioscinIBA 01/2020 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 05/2016 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 06/2012 - 08/2011
2	icotinibIBA 06/2012 - 08/2011
2	Tyrosine Kinase InhibitorsIBA 06/2012 - 08/2011
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	LigandsIBA 04/2021
1	CrizotinibIBA 01/2021
1	Circular RNAIBA 11/2020
1	SmokeIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 12/2018
1	honokiolIBA 12/2018
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	deguelinIBA 01/2017
1	Interleukin-23 (Interleukin 23)IBA 08/2016
1	Interleukin-17 (Interleukin 17)IBA 08/2016
1	InterleukinsIBA 05/2016
1	OvalbuminIBA 05/2016
1	Messenger RNA (mRNA)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Gefitinib (Iressa)FDA Link 06/2012
1	PlatinumIBA 08/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2022 - 08/2011
1	Immunotherapy 04/2021
1	Therapeutics 12/2018